Pectin does not inhibit intestinal carcinogenesis in APC-deficient Min/+ mice

Journal of Agricultural and Food Chemistry
Gisela JacobaschDetlef Schmiedl

Abstract

APC-germline mutation creates predisposition for intestinal tumorigenesis. APCMin/+ mice, developing tumors preferentially in the small intestine and only minimally in the colon, were fed pectin-enriched diets (10% galacturonan; degree of methoxylation=37.0 and 70.4%) or standard diet. Pectins used in the present study do not inhibit intestinal tumorigenesis and rather accelerate it in APCMin/+ mice. Both pectins exhibited prebiotic effects associated with high fermentative formation of acetate but producing low butyrate. The differences of the short-chain fatty acid concentrations between cecum and colon and those between colon and feces were larger than expected and increased with cancer progression, indicating an inhibition of butyrate absorption. Pectins transported more bile acids toward the colon than the standard diet and caused a higher generation of secondary bile acids despite lower pH values. Overexpression of COX-2 resulted in lower antioxidative capacity, thus promoting cancer. Apoptosis increased in hyperplasia but decreased in late adenomas. When biological modular design principles are taken into consideration, it can be expected that pectin also reinforces colorectal tumorigenesis of patients suffering from APC...Continue Reading

References

Jan 1, 1993·Scientific American·N Sharon, H Lis
Jan 11, 1996·Journal of Biochemical and Biophysical Methods·I N Popov, G Lewin
Feb 1, 1997·Critical Reviews in Food Science and Nutrition·B R ThakurA K Handa
Jan 1, 1997·Annals of Nutrition & Metabolism·M Tamura, H Suzuki
Jan 27, 1998·The Journal of Biological Chemistry·F ZhangA J Dannenberg
May 23, 1998·Annual Review of Pharmacology and Toxicology·J R VaneR M Botting
Mar 21, 2002·Nature Reviews. Cancer·P MarksW K Kelly
Mar 29, 2002·International Journal of Cancer. Journal International Du Cancer·Sandra TanShing Chuan Hooi
Dec 19, 2002·Journal of the National Cancer Institute·Pratima Nangia-MakkerAvraham Raz
Jan 24, 2004·Journal of Hepatology·Kohei OgawaAkiharu Watanabe
Apr 6, 2004·Biochemical and Biophysical Research Communications·Xin TongCharles Giardina
Apr 8, 2004·The Journal of Nutritional Biochemistry·Gerhard Dongowski, Angelika Lorenz
Jun 9, 2004·The British Journal of Nutrition·Sylvia H DuncanHarry J Flint
Sep 18, 2004·Cancer Research·Tatsuo ShimuraAvraham Raz
Jun 14, 2005·Biomaterials·Linshu LiuMeir Kende
Jun 22, 2005·Neoplasia : an International Journal for Oncology Research·Olga V GlinskiiVladislav V Glinsky
May 11, 2006·Integrative Cancer Therapies·Mark F McCarty, Keith I Block
May 20, 2006·International Journal of Experimental Pathology·Shaojin YouWilliam J M Hrushesky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.